Baseline Laboratory Assessment Before initiating GHK-Cu therapy, obtain: Serum copper level (normal range: 70 to 140 mcg/dL) Ceruloplasmin (normal range: 20 to 35 mg/dL) 24-hour urine copper (to exclude copper overload states) Hepatic function panel (AST, ALT, alkaline phosphatase, total bilirubin) Complete blood count with differential Wound photography and planimetric measurement (length, width, area) Wound culture if signs of infection are present Patients with Wilson disease, known copper storage disorders, or hepatic cirrhosis should not receive exogenous copper peptides [13]
Every published in-vivo dose was given intravenously or intraperitoneally, and nobody has measured how much of a subcutaneous dose reaches circulation
But thats provided the meals are nutritionally dense
I mean, what do you think of even before doing it in IRL, even doing the whole filming thing
Then in 1953, Helmet Ferner at the University of Hamburg, established that two hormones were secreted by the A and B cells of the pancreatic islets